Lista de obras -

A Practical Guide to Immunoassay Method Validation

artículo científico publicado en 2015

A novel Abeta isoform pattern in CSF reflects gamma-secretase inhibition in Alzheimer disease

artículo científico publicado en 2010

Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders

artículo científico publicado en 2012

Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography

artículo científico publicado en 2014

Acute effect on the Aβ isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs

artículo científico publicado en 2010

Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate

artículo científico publicado en 2017

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

artículo científico publicado en 2009

Amyloid-β metabolism in Niemann-Pick C disease models and patients

artículo científico publicado en 2012

Amyloid-β(1-15/16) as a marker for γ-secretase inhibition in Alzheimer's disease

artículo científico publicado en 2012

An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid

artículo científico publicado en 2006

Analytical aspects of molecular Alzheimer's disease biomarkers

artículo científico publicado en 2012

Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease

artículo científico publicado en 2014

Aspects of beta-amyloid as a biomarker for Alzheimer's disease

artículo científico publicado en 2007

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease

artículo científico publicado en 2017

Aβ1-15/16 as a potential diagnostic marker in neurodegenerative diseases

artículo científico publicado en 2012

BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

artículo científico publicado en 2010

BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system

artículo científico publicado en 2012

Blood biomarkers indicate mild neuroaxonal injury and increased amyloid β production after transient hypoxia during breath-hold diving

artículo científico publicado en 2016

Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder

artículo científico publicado en 2017

Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment

artículo científico publicado en 2014

C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease

artículo científico publicado en 2015

C3 deficiency ameliorates the negative effects of irradiation of the young brain on hippocampal development and learning

artículo científico publicado en 2016

CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation

artículo científico publicado en 2016

CSF Aβ42 predicts early-onset dementia in Parkinson disease

artículo científico publicado en 2014

CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study

artículo científico publicado en 2010

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

artículo científico publicado en 2016

CSF antithrombin III and disruption of the blood-brain barrier

artículo científico publicado en 2009

CSF biomarker variability in the Alzheimer's Association quality control program

artículo científico publicado en 2013

CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease

artículo científico publicado en 2010

Central and peripheral leptin and agouti-related protein during and after pregnancy in relation to weight change

artículo científico publicado en 2017

Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease

artículo científico publicado en 2013

Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection

artículo científico publicado en 2013

Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease

artículo científico publicado en 2012

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

artículo científico publicado en 2017

Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population

artículo científico publicado en 2011

Cerebrospinal fluid biomarkers in cardiac arrest survivors

artículo científico publicado en 2013

Cerebrospinal fluid brain injury biomarkers in children: a multicenter study

artículo científico publicado en 2013

Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease

article

Cerebrospinal fluid levels of insulin, leptin, and agouti-related protein in relation to BMI in pregnant women

artículo científico publicado en 2016

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

artículo científico publicado en 2014

Cerebrospinal fluid markers of neuronal and glial cell damage in patients with autoimmune neurologic syndromes with and without underlying malignancies

artículo científico publicado en 2017

Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease

artículo científico publicado en 2011

Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility.

artículo científico publicado en 2011

Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease

artículo científico publicado en 2015

Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease

artículo científico publicado en 2012

Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease

artículo científico publicado en 2014

Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease.

artículo científico publicado en 2015

Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry

artículo científico publicado en 2007

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls

artículo científico publicado en 2015

Circulating levels of vascular endothelial growth factor and post-stroke long-term functional outcome

scientific article published on 22 January 2020

Comment on "An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice".

artículo científico publicado en 2014

Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics

artículo científico publicado en 2016

Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa

artículo científico publicado en 2016

Complement gene single nucleotide polymorphisms and biomarker endophenotypes of Alzheimer's disease

artículo científico publicado en 2013

Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid

artículo científico publicado en 2010

Converging pathways of chromogranin and amyloid metabolism in the brain

artículo científico publicado en 2010

Corrigendum to: "Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study" [EBioMedicine 3 (216) 135-140].

artículo científico publicado en 2016

Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative Diseases

artículo científico publicado en 2011

Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis

artículo científico publicado en 2015

Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease

artículo científico publicado en 2010

Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease

artículo científico publicado en 2008

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease

artículo científico publicado en 2013

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

artículo científico publicado en 2008

Evaluation of the performance of novel Aβ isoforms as theragnostic markers in Alzheimer's disease: from the cell to the patient

artículo científico publicado en 2012

Explorative and targeted neuroproteomics in Alzheimer's disease

artículo científico publicado en 2015

Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid

artículo científico publicado en 2014

Human cerebrospinal fluid increases the excitability of pyramidal neurons in the in vitro brain slice

artículo científico publicado en 2014

Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid

artículo científico publicado en 2009

Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease.

artículo científico publicado en 2015

Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease

scientific article published on May 2016

Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease

artículo científico publicado en 2014

Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment

artículo científico publicado en 2012

Low Circulating Acute Brain-Derived Neurotrophic Factor Levels Are Associated With Poor Long-Term Functional Outcome After Ischemic Stroke

artículo científico publicado en 2016

Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's disease

artículo científico publicado en 2013

Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluid.

artículo científico publicado en 2014

Measurement of Aβ1-42 in cerebrospinal fluid is influenced by matrix effects.

artículo científico publicado en 2011

Multiplexing and multivariate analysis in neurodegeneration

artículo científico publicado en 2012

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease

artículo científico publicado en 2015

Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study.

artículo científico publicado en 2018

No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF.

artículo científico publicado en 2016

Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment

artículo científico publicado en 2011

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

artículo científico publicado en 2015

Plasma tau in Alzheimer disease

scientific article published on 30 September 2016

Plasma tau levels in Alzheimer's disease

artículo científico publicado en 2013

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.

artículo científico publicado en 2007

Prevalence of preclinical Alzheimer disease: Comparison of current classification systems.

artículo científico publicado en 2018

Proficiency testing programs for Alzheimer's disease cerebrospinal fluid biomarkers

artículo científico publicado en 2012

Proteomic profiling of cerebrospinal fluid in parkinsonian disorders

artículo científico publicado en 2010

Proteomics/peptidomics tools to find CSF biomarkers for neurodegenerative diseases

artículo científico publicado en 2009

Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease

artículo científico publicado en 2017

Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment

artículo científico publicado en 2017

Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42 /Aβ1-40 ratio - a cross-validation study against amyloid PET.

artículo científico publicado en 2016

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.

artículo científico

Screening for new biomarkers for subcortical vascular dementia and Alzheimer's disease

artículo científico publicado en 2011

Serum Neurofilament Light in American Football Athletes Over the Course of a Season

artículo científico publicado en 2015

Serum erythropoietin and outcome after ischaemic stroke: a prospective study

artículo científico publicado en 2016

Serum neurofilament light protein predicts clinical outcome in traumatic brain injury

artículo científico publicado en 2016

Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease

artículo científico publicado en 2013

Subcortical vascular dementia biomarker pattern in mild cognitive impairment.

artículo científico publicado en 2009

Targeted proteomics in Alzheimer's disease: focus on amyloid-beta

artículo científico publicado en 2008

Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid

artículo científico publicado en 2015

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

artículo científico publicado en 2011

The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology

artículo científico publicado en 2017

Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders

artículo científico publicado en 2016

β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage

artículo científico publicado en 2014

Lista de obras de

A Practical Guide to Immunoassay Method Validation

A novel Abeta isoform pattern in CSF reflects gamma-secretase inhibition in Alzheimer disease

Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders

Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography

Acute effect on the Aβ isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs

Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

Amyloid-β metabolism in Niemann-Pick C disease models and patients

Amyloid-β(1-15/16) as a marker for γ-secretase inhibition in Alzheimer's disease

An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid

Analytical aspects of molecular Alzheimer's disease biomarkers

Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease

Aspects of beta-amyloid as a biomarker for Alzheimer's disease

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease

Aβ1-15/16 as a potential diagnostic marker in neurodegenerative diseases

BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system

Blood biomarkers indicate mild neuroaxonal injury and increased amyloid β production after transient hypoxia during breath-hold diving

Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder

Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment

C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease

C3 deficiency ameliorates the negative effects of irradiation of the young brain on hippocampal development and learning

CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation

CSF Aβ42 predicts early-onset dementia in Parkinson disease

CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

CSF antithrombin III and disruption of the blood-brain barrier

CSF biomarker variability in the Alzheimer's Association quality control program

CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease

Central and peripheral leptin and agouti-related protein during and after pregnancy in relation to weight change

Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease

Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection

Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population

Cerebrospinal fluid biomarkers in cardiac arrest survivors

Cerebrospinal fluid brain injury biomarkers in children: a multicenter study

Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease

Cerebrospinal fluid levels of insulin, leptin, and agouti-related protein in relation to BMI in pregnant women

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

Cerebrospinal fluid markers of neuronal and glial cell damage in patients with autoimmune neurologic syndromes with and without underlying malignancies

Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease

Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility.

Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease

Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease

Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease

Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease.

Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls

Circulating levels of vascular endothelial growth factor and post-stroke long-term functional outcome

Comment on "An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice".

Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics

Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa

Complement gene single nucleotide polymorphisms and biomarker endophenotypes of Alzheimer's disease

Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid

Converging pathways of chromogranin and amyloid metabolism in the brain

Corrigendum to: "Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study" [EBioMedicine 3 (216) 135-140].

Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative Diseases

Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis

Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease

Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

Evaluation of the performance of novel Aβ isoforms as theragnostic markers in Alzheimer's disease: from the cell to the patient

Explorative and targeted neuroproteomics in Alzheimer's disease

Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid

Human cerebrospinal fluid increases the excitability of pyramidal neurons in the in vitro brain slice

Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid

Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease.

Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease

Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease

Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment

Low Circulating Acute Brain-Derived Neurotrophic Factor Levels Are Associated With Poor Long-Term Functional Outcome After Ischemic Stroke

Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's disease

Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluid.

Measurement of Aβ1-42 in cerebrospinal fluid is influenced by matrix effects.

Multiplexing and multivariate analysis in neurodegeneration

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease

Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study.